[1]
B. Demirelli, “Renal and Hemodynamic Effects of Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Type 2 Diabetes and Chronic Kidney Disease Receiving Varying Doses of Renin-Angiotensin System Blockade: Renal and Hemodynamic Effects of SGLT2i”, J Eur Int Med Prof, vol. 3, no. 3, pp. 117–123, Aug. 2025.